Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata

MeSH terms

• Adult
• Alopecia Areata* / drug therapy
• Dermatitis, Atopic* / complications
• Dermatitis, Atopic* / drug therapy
• Female
• Heterocyclic Compounds, 3-Ring* / therapeutic use
• Humans
• Janus Kinase 1 / antagonists & inhibitors
• Janus Kinase Inhibitors / therapeutic use
• Male
• Severity of Illness Index
• Treatment Outcome